These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 28348748)
1. Paediatric meningococcaemia in northwestern Ontario, Canada: a case for publicly funded meningococcal B vaccination. Eton V; Tsang RS; Ulanova M JMM Case Rep; 2016 Feb; 3(1):e005017. PubMed ID: 28348748 [TBL] [Abstract][Full Text] [Related]
2. [Meningococcemia and meningitis due to Neisseria meningitidis W135 developed in two cases vaccinated with bivalent (A/C) meningococcal vaccine]. Turhan V; Acar A; Kılıç A; Budak S; Oncül O; Haznedaroğlu T; Görenek L Mikrobiyol Bul; 2010 Jul; 44(3):473-8. PubMed ID: 21063998 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment. Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749 [TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada. Tu HA; Deeks SL; Morris SK; Strifler L; Crowcroft N; Jamieson FB; Kwong JC; Coyte PC; Krahn M; Sander B Vaccine; 2014 Sep; 32(42):5436-46. PubMed ID: 25131732 [TBL] [Abstract][Full Text] [Related]
5. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan. Kawasaki Y; Matsubara K; Takahashi H; Morita M; Ohnishi M; Hori M; Isome K; Iwata A; Nigami H; Ikemachi M; Yamamoto G; Ohkusu K J Infect Chemother; 2018 Apr; 24(4):305-308. PubMed ID: 29233459 [TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. de Moraes JC; Perkins BA; Camargo MC; Hidalgo NT; Barbosa HA; Sacchi CT; Landgraf IM; Gattas VL; Vasconcelos Hde G Lancet; 1992 Oct; 340(8827):1074-8. PubMed ID: 1357461 [TBL] [Abstract][Full Text] [Related]
7. Noteman TW; Ha TT; Tsarfati EM BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32532902 [TBL] [Abstract][Full Text] [Related]
8. [Meningococcemia: Different Serotypes in the Same Region]. Aladağ Çiftdemir N; Duran R; Vatansever Özbek Ü; Hançerli Törün S; Acunaş B; Ünal Şahin N Mikrobiyol Bul; 2020 Jan; 54(1):163-170. PubMed ID: 32050887 [TBL] [Abstract][Full Text] [Related]
9. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012]. Cui XL; Wu X; Li MQ Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112 [No Abstract] [Full Text] [Related]
10. Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants. Morley SL; Cole MJ; Ison CA; Camaraza MA; Sotolongo F; Anwar N; Cuevas I; Carbonero M; Campa HC; Sierra G; Levin M Pediatr Infect Dis J; 2001 Nov; 20(11):1054-61. PubMed ID: 11734711 [TBL] [Abstract][Full Text] [Related]
11. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218 [No Abstract] [Full Text] [Related]
12. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001. Tsang RS; Squires SG; Tam TW Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. Noronha CP; Struchiner CJ; Halloran ME Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439 [TBL] [Abstract][Full Text] [Related]
14. Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987-2013. Husain EH; Barakat M; Al-Saleh M J Infect Public Health; 2015; 8(5):441-7. PubMed ID: 25779346 [TBL] [Abstract][Full Text] [Related]
15. Vaccination against serogroup B Neisseria meningitidis: Perceptions and attitudes of parents. Le Ngoc Tho S; Ader F; Ferry T; Floret D; Arnal M; Fargeas S; Chidiac C; Valour F Vaccine; 2015 Jul; 33(30):3463-70. PubMed ID: 26055293 [TBL] [Abstract][Full Text] [Related]
16. Serogroup B Meningococcal Sepsis and Meningitis Associated With Meningococcal Acute Otitis Media, and Paranasal Sinusitis in an Infant: A Case Report. Chacon-Cruz E; Lopatynsky EZ Cureus; 2023 May; 15(5):e38430. PubMed ID: 37273326 [TBL] [Abstract][Full Text] [Related]
17. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy. Pace D Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410 [TBL] [Abstract][Full Text] [Related]
18. Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease. Watson PS; Turner DP Vaccine; 2016 Feb; 34(7):875-80. PubMed ID: 26686570 [TBL] [Abstract][Full Text] [Related]